PMGC Holdings Inc.
corporate_fare Company Profile
PMGC Holdings Inc. (NASDAQ:ELAB) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 58 items for ELAB at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-02, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 9 rated 8 or above. Recent SEC coverage for ELAB spans 8-K, 10-Q, SCHEDULE 13D, SCHEDULE 13D/A.
Recent high-impact activity:
- PMGC Authorizes 1.5B Shares and Formalizes AI Drug Expansion Program
- NorthStrive Biosciences Expands AI Drug Discovery with Yuva, Targets Lead Nomination
- PMGC Ends Arizona Acquisition LOI, Inks Orbit2Orbit Space Partnership Term Sheet
- PMGC Holdings Terminates Acquisition LOI After Due Diligence
- PMGC Holdings Announces 1-for-10 Reverse Split Effective August 21
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for ELAB, detected from its recent SEC filings · based on capital-structure filings through 2026-04-27.
Equity Drawdown Finalized · Dilutive Terms
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →